Tumor-specific genetic expression profile of metastatic oral squamous cell carcinoma

Head and Neck

Volumn 29, Issue 9, 2007, Pages 803-814

  Méndez, Eduardo ^a,b,c   Fan, Wenhong ^c   Choi, Peter ^a   Agoff, S Nicholas ^d   Whipple, Mark ^a   Farwell, D Gregory ^e   Futran, Neal D ^a   Weymuller Jr , Ernest A ^a   Zhao, Lue Ping ^c,f   Chen, Chu ^a,c,f  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b VA PUGET SOUND HEALTH CARE SYSTEM   (United States)

^c Fred Hutchinson Cancer Research Center   (United States)

^d VIRGINIA MASON MEDICAL CENTER   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Genetic profiles; Lymph nodes; Metastasis; Oral cancer; Oral squamous cell carcinoma

Indexed keywords

CYTOKERATIN 16; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE 3; UNCLASSIFIED DRUG;

ARTICLE; CELL ISOLATION; CLINICAL ARTICLE; GENE CLUSTER; GENE EXPRESSION; GENE EXPRESSION PROFILING; HUMAN; HUMAN CELL; HUMAN GENOME; HUMAN TISSUE; HYPOTHESIS; IMMUNOHISTOCHEMISTRY; LASER CAPTURE MICRODISSECTION; LYMPH NODE; LYMPH NODE METASTASIS; LYMPHOMA; METASTASIS; MICROARRAY ANALYSIS; MOUTH CARCINOMA; PRINCIPAL COMPONENT ANALYSIS; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA; TUMOR CELL;

CARCINOMA, SQUAMOUS CELL; DOWN-REGULATION; GENE EXPRESSION PROFILING; HUMANS; IMMUNOHISTOCHEMISTRY; KERATIN-16; LYMPHATIC METASTASIS; METALLOPROTEINS; MICRODISSECTION; MOUTH FLOOR; MOUTH NEOPLASMS; NUCLEAR PROTEINS; OROPHARYNGEAL NEOPLASMS; PRINCIPAL COMPONENT ANALYSIS; RIBOSOMAL PROTEINS; RNA-BINDING PROTEINS; SIGNAL TRANSDUCTION; TONGUE NEOPLASMS; TRANSGLUTAMINASES; UP-REGULATION;

EID: 37349110011     PISSN: 10433074     EISSN: 10970347     Source Type: Journal    
DOI: 10.1002/hed.20598     Document Type: Article

References (35)

1. Carvalho AL, Nishimoto IN, Califano JA, Kowalski LP. Trends in incidence and prognosis for head and neck cancer in the United States: a site-specific analysis of the SEBR database. Int J Cancer 2005;114:806-816.
2. Levin PA, Seidman D. Neoplasms of the oral cavity. In: Bailey BJ, editor. Head and neck surgery - otolaryngology, 2nd ed. Philadelphia: Lippincott-Raven; 1998. pp 1523-1539.
3. van't Veer LJ, Dai H, van de Vijver MJ, et al. Gene expression profiling predicts clinical outcome of breast cancer. Nature 2002;415:530-536.
4. van de Vijver MJ, He YD, van't Veer LJ, et al. A gene-expression signature as a predictor of survival in breast cancer. N Engl J Med 2002;347:1999-2009.
5. Kang Y, Siegel PM, Shu W, et al. A multigenic program mediating breast cancer metastasis to bone. Cancer Cell 2003;3:537-549.
6. Hynes RO. Metastatic potential: generic predisposition of the primary tumor or rare, metastatic variants - or both? Cell 2003;113:821-823.
7. Greene FL. AJCC cancer staging manual, 6th ed. New York: Springer-Verlag; 2002.
8. Zhao LP, Prentice R, Breeden L. Statistical modeling of large microarray data sets to identify stimulus-response profiles. Proc Natl Acad Sci U S A 2001;98:5631-5636.
9. Liang KY, Zeger SL. Longitudinal data analysis using generalized linear models. Biometrika 1986;73:13-22.
10. Thomas JG, Olson JM, Tapscott SJ, Zhao LP. An efficient and robust statistical modeling approach to discover differentially expressed genes using genomic expression profiles. Genome Res 2001;11:1227-1236.
11. Xu XL, Olson JM, Zhao LP. A regression-based method to identify differentially expressed genes in microarray time course studies and its application in an inducible Huntington's disease transgenic model. Hum Mol Genet 2002;11:1977-1985.
12. Hitomi K, Presland RB, Nakayama T, Fleckman P, Dale BA, Maki M. Analysis of epidermal-type transglutaminase (transglutaminase 3) in human stratified epithelia and cultured keratinocytes using monoclonal antibodies. J Dermatol Sci 2003;32:95-103.
13. Perou CM, Sorlie T, Eisen MB, et al. Molecular portraits of human breast tumours. Nature 2000;406:747-752.
14. Ginos MA, Page GP, Michalowicz BS, et al. Identification of a gene expression signature associated with recurrent disease in squamous cell carcinoma of the head and neck. Cancer Res 2004;64:55-63.
15. Leethanakul C, Knezevic V, Patel V, et al. Gene discovery in oral squamous cell carcinoma through the Head and Neck Cancer Genome Anatomy Project: confirmation by microarray analysis. Oral Oncol 2003;39:248-258.
16. Gonzalez HE, Gujrati M, Frederick M, et al. Identification of 9 genes differentially expressed in head and neck squamous cell carcinoma. Arch Otolaryngol Head Neck Surg 2003;129:754-759.
17. Sok JC, Kuriakose MA, Mahajan VB, Pearlman AN, DeLacure MD, Chen FA. Tissue-specific gene expression of head and neck squamous cell carcinoma in vivo by complementary DNA microarray analysis. Arch Otolaryngol Head Neck Surg 2003;129:760-770.
18. Ha PK, Benoit NE, Yochem R, et al. A transcriptional progression model for head and neck cancer. Clin Cancer Res 2003;9:3058-3064.
19. Cromer A, Carles A, Millon R, et al. Identification of genes associated with tumorigenesis and metastatic potential of hypopharyngeal cancer by microarray analysis. Oncogene 2004;23:2484-2498.
20. Kuriakose MA, Chen WT, He ZM, et al. Selection and validation of differentially expressed genes in head and neck cancer. Cell Mol Life Sci 2004;61:1372-1383.
21. Roepman P, Wessels LF, Kettelarij N, et al. An expression profile for diagnosis of lymph node metastases from primary head and neck squamous cell carcinomas. Nat Genet 2005;37:182-186.
22. O'Donnell RK, Kupferman M, Wei SJ, et al. Gene expression signature predicts lymphatic metastasis in squamous cell carcinoma of the oral cavity. Oncogene 2005; 24:1244-1251.
23. Choi P, Chen C. Genetic expression profiles and biologic pathway alterations in head and neck squamous cell carcinoma. Cancer 2005;104:1113-1128.
24. Schmalbach CE, Chepeha DB, Giordano TJ, et al. Molecular profiling and the identification of genes associated with metastatic oral cavity/pharynx squamous cell carcinoma. Arch Otolaryngol Head Neck Surg 2004;130:295-302.
25. Chen BS, Wang MR, Xu X, et al. Transglutaminase-3, an esophageal cancer-related gene. Int J Cancer 2000;88:862-865.
26. 2+-relevant and differentiation-associated genes downregulated in esophageal squamous cell carcinoma using cDNA microarray. Oncogene 2004;23:1291-1319.
27. Morifuji M, Taniguchi S, Sakai H, Nakabeppu Y, Ohishi M. Differential expression of cytokeratin after orthotopic implantation of newly established human tongue cancer cell lines of defined metastatic ability. Am J Pathol 2000;156:1317-1326.
28. Naora H. Involvement of ribosomal proteins in regulating cell growth and apoptosis: translational modulation or recruitment for extraribosomal activity? Immunol Cell Biol 1999;77:197-205.
29. Mendez E, Cheng C, Farwell DG, et al. Transcriptional expression profiles of oral squamous cell carcinomas. Cancer 2002;95:1482-1494.
30. Stack BC Jr, Hollenbeak CS, Lee CM, Dunphy FR, Lowe VJ, Hamilton PD. Metallopanstimulin as a marker for head and neck cancer. World J Surg Oncol 2005;2:45.
31. Wadsworth JT, Somers KD, Stack BC Jr, et al. Identification of patients with head and neck cancer using serum protein profiles. Arch Otolaryngol Head Neck Surg 2004;130:98-104.
32. Fidler IJ, Kripke ML. Metastasis results from preexisting variant cells within a malignant tumor. Science 1977;197:893-895.
33. Clark EA, Golub TR, Lander ES, Hynes RO. Genomic analysis of metastasis reveals an essential role for RhoC. Nature 2000;406:532-535. Erratum appears in Nature 2001;411:974.
34. Fidler IJ. Critical determinants of cancer metastasis: rationale for therapy. Cancer Chemother Pharmacol 1999;43(Suppl):S3-S10.
35. Fidler IJ, Hart IR. The origin of metastatic heterogeneity in tumors. Eur J Cancer (Oxford) 1981;17:487-494.